About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Maiwei Bio said its internally developed antibody candidate 9MW5211 received approval from China’s NMPA to start clinical trials for multiple sclerosis (MS). 9MW5211 previously won clearance in China and the US to enter trials for inflammatory bowel

2026-06-24

Maiwei Bio said its internally developed antibody candidate 9MW5211 received approval from China’s NMPA to start clinical trials for multiple sclerosis (MS). 9MW5211 previously won clearance in China and the US to enter trials for inflammatory bowel disease (IBD). Applications to test additional indications are underway.

Other News
2026-06-24

MSCI: If the Indonesian market fails to make significant progress by the time of the MSCI index review in November 2026, MSCI will consider a range of options to determine the appropriate treatment of the Indonesian market.

MSCI: If the Indonesian market fails to make significant progress by the time of the MSCI index review in November 2026, MSCI will consider a range of options to determine the appropriate treatment of the Indonesian market.
2026-06-23

Phase I of a large single-site AI compute cluster in Huailai County, Zhangjiakou has entered full operation, deploying more than 200,000 servers, many used by domestic internet firms for large-model training and inference. The cluster Reportedly cons

Phase I of a large single-site AI compute cluster in Huailai County, Zhangjiakou has entered full operation, deploying more than 200,000 servers, many used by domestic internet firms for large-model training and inference. The cluster Reportedly consumes over 1,000,000 kWh per hour (≈1,000 MW) at run-rate. Zhangjiakou’s developable wind capacity exceeds 40 GW, supplying abundant green power to the compute site. A nearby compute center also commissioned a new machine-hall in May. Data show China’s compute centers are estimated to consume 170 billion kWh in 2025, about 1.6% of national power use, while green power trading volume is estimated at 328.5 billion kWh in 2025. Industry participants expect coordinated national deployment of green power and compute during the 15th Five-Year Plan period to expand upstream and downstream industrial-chain opportunities.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.